Two arthritis specialists, working independently of one another at different medical schools (Albany Medical College, N.Y., and Harvard University), have both had good results with salmon oil capsules (Maxepa) when studying their effect in patients with rheumatoid arthritis.
While receiving Maxepa (15-20 capsules daily), the patients experienced both fewer painful joints and less morning stiffness, changes that did not occur when the patients (without knowing it) received capsules of a placebo instead. These findings were statistically significant, Medical World News (27#13:9) reports. While none of their patients became completely symptom-free during these clinical trials, the doctors pointed out that the treatment periods were very brief (just a few weeks), and that much longer trials will be needed to determine just how active Maxepa really is against arthritis.
Maxepa is technically a “food” rather than a drug, and it has been taken by a very large number of people for many years for the reduction of cholesterol blood levels and the prevention of hardening of the arteries. It is an over-the-counter product marketed by R.P.Scherer Corporation, and it has never been reported to cause side effects of any kind. However, Maxepa has not yet been approved by the Food and Drug Administration for treatment of arthritis.